Constructor Group

Constructor Group is a global private research, education, and technology ecosystem dedicated to addressing global challenges through science and advanced technology. The group operates three primary pillars: Constructor Knowledge (including Constructor University and Constructor Institute of Technology), Constructor Tech (AI-driven platforms for research and education), and Constructor Capital (a venture capital arm). Its research efforts are deeply integrated with its academic institutions, focusing on fields such as Artificial Intelligence, Quantum Technology, and Life Sciences. In the pharmaceutical and biotechnology space, the group operates significant R&D activities through its Medicinal Chemistry and Chemical Biology research groups. These units focus on the discovery of next-generation anti-infective and antitumor agents. Key research achievements include the development of the antifungal candidate Amphamide and the antitumor drug candidate Olivamide. The ecosystem is designed to bridge the gap between fundamental academic research and commercial technology application, leveraging a network of world-class scientists and entrepreneurs.